Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1966 1
1984 3
1988 2
1989 22
1990 41
1991 83
1992 121
1993 156
1994 223
1995 235
1996 274
1997 324
1998 288
1999 332
2000 328
2001 339
2002 402
2003 294
2004 360
2005 369
2006 364
2007 441
2008 394
2009 448
2010 419
2011 453
2012 427
2013 415
2014 384
2015 412
2016 437
2017 393
2018 421
2019 401
2020 389
Text availability
Article attribute
Article type
Publication date

Search Results

9,560 results
Results by year
Filters applied: . Clear all
Page 1
HLA-DRB1 polymorphisms and alopecia areata disease risk: A systematic review and meta-analysis.
Ji C, Liu S, Zhu K, Luo H, Li Q, Zhang Y, Huang S, Chen Q, Cao Y. Ji C, et al. Medicine (Baltimore). 2018 Aug;97(32):e11790. doi: 10.1097/MD.0000000000011790. Medicine (Baltimore). 2018. PMID: 30095639 Free PMC article. Review.
For HLA-DRB1*0301, HLA-DRB1*09, and HLA-DRB1*13 polymorphisms, the OR (95% CIs) was 0.42 (0.28-0.63), 0.74 (0.55-0.99), and 0.62 (0.40-0.98), and P was <.01, <.01, and <.01, respectively. ...CONCLUSION: The present meta-analysis …
For HLA-DRB1*0301, HLA-DRB1*09, and HLA-DRB1*13 polymorphisms, the OR (95% CIs) was 0.42 (0.28-0.6 …
The HLA-DRB1 allele polymorphisms and nasopharyngeal carcinoma.
Yang H, Yu K, Zhang R, Li J, Wei X, Zhang Y, Zhang C, Xiao F, Zhao D, Lin X, Wu H, Yang X. Yang H, et al. Tumour Biol. 2016 Jun;37(6):7119-28. doi: 10.1007/s13277-016-5051-9. Epub 2016 Apr 8. Tumour Biol. 2016. PMID: 27059731 Review.
The results showed that 4 of 13 polymorphisms allele are statistically significantly associated with NPC, among them, HLA-DRB1*3, HLA-DRB1*9, and HLA-DRB1*10 may increase the risk of NPC while HLA-DRB1*01 has the opposite ef …
The results showed that 4 of 13 polymorphisms allele are statistically significantly associated with NPC, among them, HLA-DRB1
HLA-DRB1 GENE POLYMORPHISMS IN PEDIATRIC PATIENTS WITH TYPE 1 AUTOIMMUNE HEPATITIS AND TYPE 1 AUTOIMMUNE HEPATITIS OVERLAP SYNDROME WITH AUTOIMMUNE CHOLANGITIS.
Nunes MEG, Rosa DV, Fagundes EDT, Ferreira AR, Miranda DM, Ferri Liu PM. Nunes MEG, et al. Arq Gastroenterol. 2019 Aug 13;56(2):146-150. doi: 10.1590/S0004-2803.201900000-29. Arq Gastroenterol. 2019. PMID: 31460577 Free article.
The polymorphisms of the HLA-DRB1 gene were evaluated by PCR and included HLA-DRB1*03, HLA-DRB1*04, HLA-DRB1*07, and HLA-DRB1*13. ...The HLA-DRB1*04 and HLA- DRB1*07 have no associat …
The polymorphisms of the HLA-DRB1 gene were evaluated by PCR and included HLA-DRB1*03, HLA-DRB1*04 …
The distribution of HLA-DRB3 alleles among HLA-DRB1*03:01-positive haplotypes.
Stingl Jankovic K, Grubic Z, Jakupic J, Burek Kamenaric M, Maskalan M, Zunec R. Stingl Jankovic K, et al. HLA. 2018 Sep;92(3):160-163. doi: 10.1111/tan.13328. Epub 2018 Jul 30. HLA. 2018. PMID: 29959830
HLA-DRB3 allelic polymorphism on HLA-DRB1*03:01-positive haplotypes was investigated among 104 cadaveric donors typed for HLA-A, -B, -DRB1, and -DRB3. Only HLA-DRB3*01:01:02 and -DRB3*02:02:01:01 alleles were detected among HLA-
HLA-DRB3 allelic polymorphism on HLA-DRB1*03:01-positive haplotypes was investigated among 104 cadaveric donors typed f
HLA-DRB1*15:03 and HLA-DRB1*11: useful predictive alleles for alloantibody production in thalassemia patients.
Darvishi P, Sharifi Z, Azarkeivan A, Akbari A, Pourfathollah AA. Darvishi P, et al. Transfus Med. 2019 Jun;29(3):179-184. doi: 10.1111/tme.12531. Epub 2018 Apr 25. Transfus Med. 2019. PMID: 29691938 Clinical Trial.
The aim of the present study was to determine the relationship between HLA-DRB1*15:03, HLA-DRB1*11 and HLA-DRB1*09:01 alleles and alloimmunisation in Iranian thalassemia patients. ...There was a correlation between HLA-DRB1* …
The aim of the present study was to determine the relationship between HLA-DRB1*15:03, HLA-DRB1*11 and HLA
HLA-DRB1*09:01 allele is associated with anti-E immunization in a Chinese population.
Tian L, Hou L, Wang L, Xu H, Xiao J, Ying B. Tian L, et al. Transfusion. 2018 Jun;58(6):1536-1539. doi: 10.1111/trf.14568. Epub 2018 Mar 7. Transfusion. 2018. PMID: 29516495
HLA-DRB1 genotyping was carried out using sequence-based typing method. The TEPITOPEpan software was used to predict E antigen-derived anchor peptides binding to HLA-DRB1 molecules. ...One E antigen-derived anchor peptide (217WMFWPSVNS225) was predicte
HLA-DRB1 genotyping was carried out using sequence-based typing method. The TEPITOPEpan software was used to predict E antigen
Identification of HLA-DRB1*04:10 allele as risk allele for Japanese moyamoya disease and its association with autoimmune thyroid disease: A case-control study.
Tashiro R, Niizuma K, Khor SS, Tokunaga K, Fujimura M, Sakata H, Endo H, Inoko H, Ogasawara K, Tominaga T. Tashiro R, et al. PLoS One. 2019 Aug 14;14(8):e0220858. doi: 10.1371/journal.pone.0220858. eCollection 2019. PLoS One. 2019. PMID: 31412073 Free PMC article.
Next, the frequency of each HLA allele (HLA-A, HLA-B, HLA-C, HLA-DRB1, HLA-DQB1, and HLA-DPB1) was compared with those in the Japanese control database. ...CONCLUSIONS: HLA-DRB1*04:10 is a risk allele and HL
Next, the frequency of each HLA allele (HLA-A, HLA-B, HLA-C, HLA-DRB1, HLA-DQB1, and HLA
The association of HLA-DQB1*0602 but not HLA-DRB1*15 with obstructive sleep apnea.
Momany SM, Al-Qatarneh TA, Khader YS, Abu-Harfeil NM, Daoud AK, Mahasneh AA. Momany SM, et al. Clin Invest Med. 2017 Aug 29;40(4):E167-E175. doi: 10.25011/cim.v40i4.28494. Clin Invest Med. 2017. PMID: 28875928
No statistical difference was found in HLA-DRB1*15 between severe and non-severe OSA (P=0.499). After adjusting for gender, HLA-DQB1*0602 allele was associated with increased odds of OSA (OR = 6.17, 95% CI 1.87-20.3, p = 0.003), but HLA-DRB1*15 …
No statistical difference was found in HLA-DRB1*15 between severe and non-severe OSA (P=0.499). After adjusting for gender, …
Using next-generation sequencing for characterising HLA-DRB1 and DQB1 loci in a cohort of Colombian women.
Del Río-Ospina L, Camargo M, Soto-De León SC, Robayo-Calderón KL, Garzón-Ospina D, Patarroyo ME, Patarroyo MA. Del Río-Ospina L, et al. HLA. 2019 Nov;94(5):425-434. doi: 10.1111/tan.13672. Epub 2019 Aug 29. HLA. 2019. PMID: 31441245
Unfortunately, few reports are available regarding HLA-DRB1 and DQB1 diversity in Colombia to date. HLA-DRB1 and DQB1 diversity was identified in this study using next-generating sequencing (NGS) on a cohort of Colombian women. ...Forty-seven DRB1
Unfortunately, few reports are available regarding HLA-DRB1 and DQB1 diversity in Colombia to date. HLA-DRB1 and …
HLA-DRB1*15:01 and HLA-DRB3*02:02 in PLA2R-Related Membranous Nephropathy.
Le WB, Shi JS, Zhang T, Liu L, Qin HZ, Liang S, Zhang YW, Zheng CX, Jiang S, Qin WS, Zhang HT, Liu ZH. Le WB, et al. J Am Soc Nephrol. 2017 May;28(5):1642-1650. doi: 10.1681/ASN.2016060644. Epub 2016 Dec 27. J Am Soc Nephrol. 2017. PMID: 28028136 Free PMC article.
Two HLA risk alleles, HLA-DRB1*15:01 and HLA-DRB3*02:02, independently and strongly associated with an increased risk of PLA2R-related MN. After adjusting for HLA-DRB1*15:01 and HLA-DRB3*02:02, no other alleles showed significant a …
Two HLA risk alleles, HLA-DRB1*15:01 and HLA-DRB3*02:02, independently and strongly associated with an increased …
9,560 results
Jump to page
Feedback